Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
ImmunoMet appoints two new executives
February 12, 2018 Off

ImmunoMet appoints two new executives

By Dino Mustafić

ImmunoMet Therapeutics, a private US-based biotechnology company, on Monday appointed two new executives, for medical and financial departments.

February 12, 2018 Off

New technique for downstream bioconjugation process from ADC Biotechnology

By Dino Mustafić

ADC Biotechnology is making a new method that will present a new paradigm in Antibody Drug Conjugate (ADC) development and…

Xeris Pharmaceuticals gets new ODD from the USFDA
February 9, 2018 Off

Xeris Pharmaceuticals gets new ODD from the USFDA

By Dino Mustafić

Xeris Pharmaceuticals got its third orphane drug designation from the USFDA, this time for its treatment of Hyperinsulinemic Hypoglycemia.

BioPorto nets deal with Roche for distribution of test on Roche’s cobas analysers
February 9, 2018 Off

BioPorto nets deal with Roche for distribution of test on Roche’s cobas analysers

By Dino Mustafić

BioPorto and Roche agreed that BioPorto will deliver a neutrophil gelatinase-associated lipocalin (NGAL) test for use on Roche’s cobas c…

February 9, 2018 Off

Aquinox Pharmaceuticals enrolls the patients for testing ist lead drug candidate for bladder pain syndrome, results in Q3

By Dino Mustafić

Aquinox Pharmaceuticals has completed the list of candidates to be included in the clinical trial of its bladder pain syndrome…

February 9, 2018 Off

Immutep’s efti combination with Keytruda is safe, DSMB says

By Dino Mustafić

Immutep Limited’s combination of eftilagimod alpha with pembrolizumab (KEYTRUDA) is safe and well tolerated at doses up to 30 mg…

ViiV Healthcare sues Gilead over HIV drug containing bictegravir patent infringmenet, Gilead increases dividend 10% after posting net loss in Q4 2017
February 8, 2018 Off

ViiV Healthcare sues Gilead over HIV drug containing bictegravir patent infringmenet, Gilead increases dividend 10% after posting net loss in Q4 2017

By Dino Mustafić

ViiV Healthcare on Thursday said it has filed patent infringement litigation against Gilead Sciences Inc. over bictegravir in the United…

Novartis to update plaque psoriasis inhibitor Cosentyx
February 8, 2018 Off

Novartis to update plaque psoriasis inhibitor Cosentyx

By Dino Mustafić

Novartis got an approval from the USFDA for a label update for its plaque psoriasis inhibitor Cosentyx (secukinumab).

Circassia reaches new customers in USA through Vizient
February 8, 2018 Off

Circassia reaches new customers in USA through Vizient

By Dino Mustafić

Circassia Pharmaceuticals has received a multi-year Innovative Technology contract for its Niox Vero asthma management products from Vizient.

Pharmapack Europe Award Winners 2018
February 8, 2018 Off

Pharmapack Europe Award Winners 2018

By Dino Mustafić

Pharmapack Europe announced the winners of the much celebrated 2018 Pharmapack Awards. Due to the outstanding quality of entries, six worthy…

Posts navigation

Previous 1 … 5,174 5,175 5,176 … 5,374 Next

Popular posts

Medicago, GSK report primary and secondary endpoints with available data met in trial dominated by COVID-19 variants

December 10, 2021 Off

G1 Therapeutics Announces Upcoming Presentation at the 2023 San Antonio Breast Cancer Symposium

November 30, 2023 Off
Cosentyx meets the primary endpoints

Cosentyx meets the primary endpoints

June 15, 2015 Off
Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

June 15, 2015 Off
Strensiq in HPP patiens therapy get approval from European Commission

Strensiq in HPP patiens therapy get approval from European Commission

September 13, 2015 Off
Proudly powered by WordPress | Theme: Envo Magazine